Jesus Fuentes-Antras - IIS-Fundación Jiménez Díaz, Autónoma University

基本信息

浏览量：9

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 40 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 969: Tumor-agnostic Ctdna Monitoring in Patients with Metastatic HR+/HER2- Breast Cancer Receiving First-Line CDK4/6 Inhibitor and Endocrine Therapy

Mitchell J. Elliott,Jesús Fuentes-Antrás,Aaron Dou,Nancy Gregorio,Elizabeth Shah,Emily Van de Laar, Geethika Yalamanchili,Leylah M. Drusbosky,Eitan Amir,Michelle B. Nadler,Celeste Yu,Hal K. Berman,Lillian L. Siu,Philippe L. Bedard,David W. Cescon

Cancer Researchno. 6_Supplement (2024): 969-969

引用0浏览0引用

Pharmacokinetic (PK) and Pharmacodynamic (PD) Findings from a Phase 1b Study of ATR Inhibitor Tuvusertib + Anti-Pd-l1 Avelumab in Patients with Advanced Unresectable Solid Tumors

Anthony W. Tolcher,Lillian L. Siu,Elena Garralda Cabanas,Valentina Boni,Enrique Sanz Garcia,Jesus Fuentes-Antras,Omar Saavedra, Anna Coenen-Stass,Giuseppe Locatelli, Deepthi S. Vagge, Burak Kursad Gunhan,Gregory K. Pennock,Jatinder Kaur Mukker,Ioannis Gounaris,Timothy A. Yap

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Exploring Gastric Cancer Genetics: A Turning Point in Common Variable Immunodeficiency

Silvia Sánchez-Ramón,Jesús Fuentes-Antrás,Nicholas L. Rider,Pedro Pérez-Segura,Eduardo de la Fuente-Muñoz,Miguel Fernández-Arquero,Esmeralda Neves,Rebeca Pérez de Diego,Alberto Ocaña,Kissy Guevara-Hoyer

Journal of Allergy and Clinical Immunology Globalno. 2 (2024): 100203

引用0浏览0WOS引用

Seize the Engine: Emerging Cell Cycle Targets in Breast Cancer

Jesus Fuentes-Antras,Philippe L. Bedard,David W. Cescon

CLINICAL AND TRANSLATIONAL MEDICINEno. 1 (2024)

引用0浏览0WOS引用

Characterization of Molecular Response and Progression in Patients with Metastatic HR+/HER2- Breast Cancer Receiving Endocrine Therapy and CDK4/6 Inhibitors Using a High-Sensitivity Tumor-Informed Assay

Jesus Fuentes-Antras,Mitchell J. Elliott,Philippe Echelard,Aaron Dou,Zachary Veitch,Philippe L. Bedard,Eitan Amir,Michelle B. Nadler,Nicholas Meti,Nancy Gregorio,Elizabeth Shah,Emily Van de Laar,Celeste Yu, Lisa Gates, Clodagh Murray, Christopher G. Smith, Amber Chevalier,Lillian L. Siu,Hal K. Berman,David W. Cescon

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Abstract CT063: Phase Ib trial of ATR inhibitor (ATRi) tuvusertib + ATM inhibitor (ATMi) lartesertib (M4076) in patients (pts) with advanced solid tumors

Lillian L. Siu, Elena Garralda Cabanas,Valentina Boni,Anthony W. Tolcher,Enrique Sanz Garcia,Jesús Fuentes-Antrás,Omar Saavedra, Deepthi S. Vagge,Giuseppe Locatelli, Burak Kürsad Günhan, Gregory Pennock,Jatinder Kaur Mukker,Ioannis Gounaris,Timothy A. Yap

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors

Jesus Fuentes-Antras, Ana Martinez-Rodriguez,Kissy Guevara-Hoyer,Igor Lopez-Cade,Victor Lorca,Alejandro Pascual,Alicia de Luna,Carmen Ramirez-Ruda, Jennifer Swindell,Paloma Flores,Ana Lluch,David W. Cescon,Pedro Perez-Segura,Alberto Ocana,Frederick Jones,Fernando Moreno,Vanesa Garcia-Barberan,Jose Angel Garcia-Saenz

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 14 (2023)

引用0浏览0WOS引用

Antibody–drug Conjugates: in Search of Partners of Choice

Jesús Fuentes-Antrás,Sofia Genta,Abi Vijenthira,Lillian L. Siu

Trends in Cancerno. 4 (2023): 339-354

引用22浏览0引用

Genome-wide DNA methylation analysis identifies novel biomarkers associated with risk of relapse beyond oncotype DX recurrence-score risk assessment within HR+/HER2-early-stage breast cancer patients

Jesus Fuentes-Antras,Vanesa Garcia-Barberan,Nicolas Costa-Fraga,Fernando Moreno,Aida Bao-Caamano,Aitor Rodriguez-Casanova,Alfonso Lopez de Sa,Alicia De Luna,Igor Lopez-Cade,Carmen Ramirez-Ruda,Alejando Pascual,Pedro Perez-Segura,Balazs Gyorffy,Alberto Ocana,Angel Diaz-Lagares,Jose Angel Garcia-Saenz

CANCER RESEARCH（2022）

引用0浏览0引用

Abstract P3-05-06: Genome-wide DNA Methylation Analysis Identifies Novel Biomarkers Associated with Risk of Relapse Beyond Oncotype DX Recurrence-Score Risk Assessment Within HR+/HER2- Early-Stage Breast Cancer Patients

Jesus Fuentes-Antrás,Vanesa García-Barberán,Nicolas Costa-Fraga,Fernando Moreno,Aida Bao-Caamano,Aitor Rodríguez-Casanova,Alfonso López de Sá,Alicia De Luna,Igor Lopez-Cade,Carmen Ramirez-Ruda,Alejando Pascual,Pedro Perez-Segura,Balázs Győrffy,Alberto Ocaña,Angel Diaz-Lagares,Jose Angel Garcia-Saenz

Cancer Research（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn